Skip to main content
. 2024 Dec 23;15:1511155. doi: 10.3389/fendo.2024.1511155

Table 1.

Patient characteristics.

Characteristics All (n =15) Cushing’s disease (n =7) Adrenal Cushing’s syndrome (n =8) p value
age, y.o. 51.7 (39.0 – 64.0) 61.0 (54.0 – 65.5) 39.0 (33.5 – 54.0) 0.049
sex F/M 13/2 F/M 6/1 F/M 7/1 1.0†
height, m 1.5 (1.5 – 1.6) 1.5 (1.4 – 1.5) 1.5 (1.5 – 1.6) 0.41
body weight, kg 65.3 (52.4 – 74.8) 60.0 (48.9 – 74.5) 72.7 (59.0 – 74.3) 0.48
BMI, kg/m2 26.5 (22.6 – 30.8) 25.8 (22.2 – 29.9) 25.6 (23.2 – 30.9) 0.64
BSA, m2 1.6 (1.5 – 1.8) 1.5 (1.4 – 1.7) 1.7 (1.5 – 1.8) 0.56
early morning serum cortisol, nmol/L 604.1 (506.2 – 634.4) 642.7 (622.0 – 839.9) 535.1 (486.2 – 571.0) 0.024
late-night serum cortisol, nmol/L 556.2 (437.2 – 649.6) 664.8 (506.2 – 815.1) 528.2 (451.7 – 567.5) 0.13
serum cortisol after LDDST, nmol/L 593.0 (562.7 – 682.7) 706.2 (573.7 – 1246.8) 580.6 (515.8 – 621.3) 0.11
UFC, fold-change of ULN 6.1 (3.7 – 14.5) 16.5 (5.1 – 19.6) 4.89 (3.8 – 6.2) 0.083

Data are presented as median (IQR).

Each parameter for the groups of Cushing’s disease and adrenal Cushing’s syndrome was tested using the Mann-Whitney U test.

† For the categorical data, a Fisher's exact test was used to calculate the odds ratio and p value. The odds ratio was 0.85.

BMI, body mass index; BSA, body surface area; LDDST, low-dose dexamethasone suppression test; UFC, urinary free cortisol;

ULN, multiples of the upper limit of normal; F, female; M, male; IQR, interquartile range.